SRx Current Deferred Revenue from 2010 to 2026

SRXH Stock   0.20  0.04  16.67%   
SRx Health's Current Deferred Revenue is decreasing with slightly volatile movements from year to year. Current Deferred Revenue is predicted to flatten to about 24.8 K. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2010-12-31
Previous Quarter
26.1 K
Current Value
24.8 K
Quarterly Volatility
156 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check SRx Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SRx Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.5 K, Interest Expense of 536.9 K or Total Revenue of 5.6 M, as well as many indicators such as Price To Sales Ratio of 0.0195, Dividend Yield of 0.0 or PTB Ratio of 0.0155. SRx financial statements analysis is a perfect complement when working with SRx Health Valuation or Volatility modules.
  
Build AI portfolio with SRx Stock
Check out the analysis of SRx Health Correlation against competitors.

Latest SRx Health's Current Deferred Revenue Growth Pattern

Below is the plot of the Current Deferred Revenue of SRx Health Solutions over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. SRx Health's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SRx Health's overall financial position and show how it may be relating to other accounts over time.
Current Deferred Revenue10 Years Trend
Slightly volatile
   Current Deferred Revenue   
       Timeline  

SRx Current Deferred Revenue Regression Statistics

Arithmetic Mean228,935
Geometric Mean139,419
Coefficient Of Variation68.13
Mean Deviation142,429
Median350,000
Standard Deviation155,984
Sample Variance24.3B
Range325.2K
R-Value(0.86)
Mean Square Error6.6B
R-Squared0.75
Slope(26,708)
Total Sum of Squares389.3B

SRx Current Deferred Revenue History

202624.8 K
202526.1 K
202129 K
2020225 K

About SRx Health Financial Statements

Investors use fundamental indicators, such as SRx Health's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although SRx Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue26.1 K24.8 K

Currently Active Assets on Macroaxis

When determining whether SRx Health Solutions offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SRx Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Srx Health Solutions Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Srx Health Solutions Stock:
Check out the analysis of SRx Health Correlation against competitors.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SRx Health. If investors know SRx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SRx Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
13.04
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.11)
The market value of SRx Health Solutions is measured differently than its book value, which is the value of SRx that is recorded on the company's balance sheet. Investors also form their own opinion of SRx Health's value that differs from its market value or its book value, called intrinsic value, which is SRx Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SRx Health's market value can be influenced by many factors that don't directly affect SRx Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SRx Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if SRx Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SRx Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.